Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongrui Tian

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 7, 2022
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populationsRen Zhou, Hongchen Zheng, Mengfei Liu, et al.
Eclinicalmedicine|March 15, 2021
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in ChinaHongrui Tian, Yanjun Hu, Qingxiang Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 12, 2025
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesionsYanna Chi, Hongrui Tian, Chao Shi, et al.
Pharmacoeconomics|February 28, 2019
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled TrialFuxiao Li, Xiang Li, Chuanhai Guo, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2025
Absolute Risk Prediction for Esophageal Squamous Cell Carcinoma Adaptable to Regional Disease Burden across Diverse RegionsMengfei Liu, Yi Huang, Hongrui Tian, et al.
BMC Medicine|November 7, 2025
Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
BMC Cancer|May 14, 2026
Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control studyMengfei Liu, Hongrui Tian, Minmin Wang, et al.
British Journal of Cancer|August 5, 2025
Effect of risk-based screening for upper gastrointestinal cancers: a multi-center real-world studyHongrui Tian, Mengfei Liu, Zhen Liu, et al.
Iscience|June 4, 2024
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagusMengfei Liu, Hongrui Tian, Minmin Wang, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 7, 2022
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populationsRen Zhou, Hongchen Zheng, Mengfei Liu, et al.
Eclinicalmedicine|March 15, 2021
Estimating cancer survival and prevalence with the Medical-Insurance-System-based Cancer Surveillance System (MIS-CASS): An empirical study in ChinaHongrui Tian, Yanjun Hu, Qingxiang Li, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|May 12, 2025
Enhancing diagnostic accuracy: Role of stomach-specific serum biomarkers in real-world risk-based sequential screening for malignant gastric lesionsYanna Chi, Hongrui Tian, Chao Shi, et al.
Pharmacoeconomics|February 28, 2019
Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled TrialFuxiao Li, Xiang Li, Chuanhai Guo, et al.
BMC Medicine|July 6, 2026
Effect of endoscopic screening for non-cardia gastric cancer: a 12-year report of a population-based randomized trialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 27, 2025
Absolute Risk Prediction for Esophageal Squamous Cell Carcinoma Adaptable to Regional Disease Burden across Diverse RegionsMengfei Liu, Yi Huang, Hongrui Tian, et al.
BMC Medicine|November 7, 2025
Opening the black box: defining true-negative outcomes in esophageal cancer screening - a population-based studyMengfei Liu, Zeyu Yan, Anxiang Liu, et al.
BMC Cancer|May 14, 2026
Lipid-dominated metabolites mediate the association between low body mass index and esophageal malignancy: a population-based nested case-control studyMengfei Liu, Hongrui Tian, Minmin Wang, et al.
British Journal of Cancer|August 5, 2025
Effect of risk-based screening for upper gastrointestinal cancers: a multi-center real-world studyHongrui Tian, Mengfei Liu, Zhen Liu, et al.
Iscience|June 4, 2024
Construction and validation of serum Metabolic Risk Score for early warning of malignancy in esophagusMengfei Liu, Hongrui Tian, Minmin Wang, et al.
Pageof 4